11.48
price down icon16.27%   -2.23
after-market Handel nachbörslich: 12.00 0.52 +4.53%
loading
Schlusskurs vom Vortag:
$13.71
Offen:
$9.48
24-Stunden-Volumen:
2.18M
Relative Volume:
3.71
Marktkapitalisierung:
$722.35M
Einnahmen:
$512.35M
Nettoeinkommen (Verlust:
$-156.23M
KGV:
-2.5066
EPS:
-4.58
Netto-Cashflow:
$7.98M
1W Leistung:
-13.75%
1M Leistung:
-2.30%
6M Leistung:
+189.17%
1J Leistung:
+198.96%
1-Tages-Spanne:
Value
$7.30
$11.80
1-Wochen-Bereich:
Value
$7.30
$14.38
52-Wochen-Spanne:
Value
$3.36
$14.38

Bioventus Inc Stock (BVS) Company Profile

Name
Firmenname
Bioventus Inc
Name
Telefon
(919) 474-6700
Name
Adresse
4721 EMPEROR BOULEVARD, SUITE 100, DURHAM
Name
Mitarbeiter
1,030
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-05
Name
Neueste SEC-Einreichungen
Name
BVS's Discussions on Twitter

Bioventus Inc Stock (BVS) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2023-08-09 Hochstufung Craig Hallum Hold → Buy
2022-11-22 Herabstufung Craig Hallum Buy → Hold
2022-11-09 Herabstufung Canaccord Genuity Buy → Hold
2022-11-09 Herabstufung JP Morgan Overweight → Underweight
2022-03-15 Eingeleitet Craig Hallum Buy
2021-11-15 Fortgesetzt Morgan Stanley Overweight
2021-11-10 Fortgesetzt JP Morgan Overweight
2021-07-01 Herabstufung Goldman Buy → Neutral
2021-03-08 Eingeleitet Canaccord Genuity Buy
2021-03-08 Eingeleitet Goldman Buy
2021-03-08 Eingeleitet JP Morgan Overweight
2021-03-08 Eingeleitet Morgan Stanley Overweight
Alle ansehen

Bioventus Inc Aktie (BVS) Neueste Nachrichten

pulisher
02:36 AM

Bioventus (NYSE:BVS) Shares Gap DownHere's What Happened - MarketBeat

02:36 AM
pulisher
01:03 AM

How Are Things Looking For Bioventus Inc (NASDAQ: BVS) For The Short Term? - Stocks Register

01:03 AM
pulisher
09:13 AM

BVSBioventus Inc. Latest Stock News & Market Updates - StockTitan

09:13 AM
pulisher
08:51 AM

Bioventus: Q3 Earnings Snapshot - San Francisco Chronicle

08:51 AM
pulisher
08:26 AM

Bioventus Inc Reports Q3 2024 Earnings: Revenue Hits $139 Millio - GuruFocus.com

08:26 AM
pulisher
08:09 AM

Bioventus (NYSE:BVS) Updates FY 2024 Earnings Guidance - MarketBeat

08:09 AM
pulisher
07:49 AM

Bioventus Reports Third Quarter Financial Results - The Manila Times

07:49 AM
pulisher
07:36 AM

Bioventus reports Q3 adjusted EPS 6c, consensus 3c - TipRanks

07:36 AM
pulisher
Nov 04, 2024

Are Medical Stocks Lagging Bioventus (BVS) This Year? - Yahoo Finance

Nov 04, 2024
pulisher
Nov 04, 2024

Bioventus Inc (BVS) Q3 2024 Earnings Report Preview: What To Loo - GuruFocus.com

Nov 04, 2024
pulisher
Nov 04, 2024

Bioventus Inc (BVS) Q3 2024 Earnings Report Preview: What To Look For - Yahoo Finance

Nov 04, 2024
pulisher
Oct 31, 2024

Bioventus stock soars to 52-week high, hits $13.65 - Investing.com India

Oct 31, 2024
pulisher
Oct 30, 2024

Bioventus stock soars to 52-week high, hits $13.65 By Investing.com - Investing.com South Africa

Oct 30, 2024
pulisher
Oct 30, 2024

Bioventus (BVS) Scheduled to Post Quarterly Earnings on Tuesday - MarketBeat

Oct 30, 2024
pulisher
Oct 29, 2024

Should Bioventus Stock Be in Your Portfolio Pre-Q3 Earnings? - MSN

Oct 29, 2024
pulisher
Oct 29, 2024

Bioventus to Report Third Quarter of Fiscal Year 2024 Financial Results on November 5, 2024 - The Manila Times

Oct 29, 2024
pulisher
Oct 26, 2024

Long Term Trading Analysis for (BVS) - Stock Traders Daily

Oct 26, 2024
pulisher
Oct 23, 2024

Bioventus (NYSE:BVS) Reaches New 1-Year HighStill a Buy? - MarketBeat

Oct 23, 2024
pulisher
Oct 23, 2024

Bioventus stock soars to 52-week high, hits $13.14 - Investing.com India

Oct 23, 2024
pulisher
Oct 23, 2024

SG Americas Securities LLC Lowers Stock Position in Bioventus Inc. (NYSE:BVS) - Defense World

Oct 23, 2024
pulisher
Oct 22, 2024

Bioventus Surges 73% in Three Months: Time to Buy the Stock? - Yahoo Finance

Oct 22, 2024
pulisher
Oct 18, 2024

Are Medical Stocks Lagging ChromaDex (CDXC) This Year? - Yahoo Finance

Oct 18, 2024
pulisher
Oct 15, 2024

Bioventus stock soars to 52-week high of $12.43 amid growth By Investing.com - Investing.com South Africa

Oct 15, 2024
pulisher
Oct 14, 2024

Bioventus (NYSE:BVS) Reaches New 52-Week HighStill a Buy? - MarketBeat

Oct 14, 2024
pulisher
Oct 14, 2024

Bioventus stock soars to 52-week high of $12.43 amid growth - Investing.com Australia

Oct 14, 2024
pulisher
Oct 14, 2024

Dimensional Fund Advisors LP Buys 58,954 Shares of Bioventus Inc. (NYSE:BVS) - MarketBeat

Oct 14, 2024
pulisher
Oct 13, 2024

Bone Growth Products Global Market Report |Bioventus, Djo, Johnson & Johnson, Medtronic, Orthofix, Stryker, Zimmer Biome – IndiaPolitics.com - IndiaPolitics.com

Oct 13, 2024
pulisher
Oct 11, 2024

Bioventus (NYSE:BVS) Trading Up 7.5%Here's What Happened - MarketBeat

Oct 11, 2024
pulisher
Oct 11, 2024

Bioventus (NYSE:BVS) Shares Up 7.5%What's Next? - MarketBeat

Oct 11, 2024
pulisher
Oct 11, 2024

Buying Buzz: Bioventus Inc [BVS] Director Bartholdson John A. acquires 80,000 shares of the company - Knox Daily

Oct 11, 2024
pulisher
Oct 11, 2024

Ratio Revelations: Bioventus Inc (BVS)’s Financial Metrics in the Spotlight - The Dwinnex

Oct 11, 2024
pulisher
Oct 09, 2024

Bioventus Inc (BVS) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance

Oct 09, 2024
pulisher
Oct 09, 2024

Bioventus Inc (BVS) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada

Oct 09, 2024
pulisher
Oct 08, 2024

Bank of Montreal Can Invests $774,000 in Bioventus Inc. (NYSE:BVS) - MarketBeat

Oct 08, 2024
pulisher
Oct 05, 2024

Marshall Wace LLP Has $1.91 Million Position in Bioventus Inc. (NYSE:BVS) - MarketBeat

Oct 05, 2024
pulisher
Oct 04, 2024

U.S. Osteoarthritis Injectables Market Analysis 2024-2030: Rising Prevalence of Osteoarthritis & Increase in R&D Activities for Injectable Drug Developments Spurs Growth - GlobeNewswire Inc.

Oct 04, 2024
pulisher
Oct 01, 2024

Bioventus maintains Buy rating by Canaccord Genuity - Investing.com Canada

Oct 01, 2024
pulisher
Oct 01, 2024

Bioventus Announces Divestiture Of Its Advanced Rehabilitation Business To Accelmed Partners - citybiz

Oct 01, 2024
pulisher
Oct 01, 2024

Bioventus Announces Divestiture of its Advanced Rehabilitation Business to Accelmed Partners - The Manila Times

Oct 01, 2024
pulisher
Oct 01, 2024

Bioventus Inc. (NYSE:BVS) Holdings Reduced by Nantahala Capital Management LLC - MarketBeat

Oct 01, 2024
pulisher
Sep 30, 2024

Bioventus Inc (BVS) receives a Buy rating from Canaccord Genuity - Knox Daily

Sep 30, 2024
pulisher
Sep 28, 2024

Bioventus Inc. (NYSE:BVS) Shares Bought by Rhumbline Advisers - MarketBeat

Sep 28, 2024
pulisher
Sep 27, 2024

Bioventus stock soars to 52-week high, hits $12.15 - Investing.com

Sep 27, 2024
pulisher
Sep 27, 2024

Bioventus (NYSE:BVS) Hits New 1-Year High After Analyst Upgrade - MarketBeat

Sep 27, 2024
pulisher
Sep 27, 2024

Bioventus stock soars to 52-week high, hits $12.15 By Investing.com - Investing.com UK

Sep 27, 2024
pulisher
Sep 27, 2024

Bioventus (NYSE:BVS) Price Target Increased to $17.00 by Analysts at Craig Hallum - MarketBeat

Sep 27, 2024
pulisher
Sep 24, 2024

(BVS) Technical Data - Stock Traders Daily

Sep 24, 2024
pulisher
Sep 24, 2024

Zacks.com featured highlights include Bioventus, Great Lakes Dredge & Dock and AxoGen - Yahoo Finance

Sep 24, 2024
pulisher
Sep 24, 2024

Bank of New York Mellon Corp Invests $647,000 in Bioventus Inc. (NYSE:BVS) - MarketBeat

Sep 24, 2024
pulisher
Sep 23, 2024

The Attractiveness of Investing In Bioventus Inc (BVS) is Growing - Knox Daily

Sep 23, 2024
pulisher
Sep 23, 2024

First September Gains in 5 Years? Buy 3 Breakout Stocks Now - Yahoo Finance

Sep 23, 2024

Finanzdaten der Bioventus Inc-Aktie (BVS)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
medical_devices ZBH
$108.92
price up icon 0.47%
medical_devices STE
$227.44
price up icon 0.72%
medical_devices PHG
$27.08
price up icon 0.00%
$69.00
price down icon 1.00%
$88.17
price up icon 1.36%
medical_devices EW
$66.69
price up icon 0.33%
Kapitalisierung:     |  Volumen (24h):